Aerosolized prostacyclin in acute respiratory distress syndrome caused by Chlamydiaceae spp. pneumonia

Management of respiratory failure in acute respiratory distress syndrome (ARDS) typically requires ventilatory assistance. If traditional approaches to mechanical ventilation and adjunctive measures fail to succeed in achieving adequate oxygenation, alternative measures should be considered. We desc...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Netherlands journal of medicine 2001-08, Vol.59 (2), p.57-61
Hauptverfasser:	Miesen, W.M.A.J, Ponssen, H.H, Jansen, S, Posthuma, R.M, van Vliet, A.C.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute respiratory distress syndrome Administration, Inhalation Biological and medical sciences Chlamydiaceae Chlamydiaceae Infections - drug therapy Community-acquired pneumonia Epoprostenol - therapeutic use Humans Male Medical sciences Middle Aged Pharmacology. Drug treatments Platelet Aggregation Inhibitors - therapeutic use Pneumonia, Bacterial - drug therapy Pneumonia, Bacterial - microbiology Prostacyclin Respiratory Distress Syndrome, Adult - drug therapy Respiratory Distress Syndrome, Adult - microbiology Respiratory system Vasodilator
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Management of respiratory failure in acute respiratory distress syndrome (ARDS) typically requires ventilatory assistance. If traditional approaches to mechanical ventilation and adjunctive measures fail to succeed in achieving adequate oxygenation, alternative measures should be considered. We describe an ARDS patient with respiratory failure caused by a severe Chlamydiaceae species community-acquired pneumonia (CAP). Aerosolized prostacyclin (PGI2) treatment was successfully instituted for refractory hypoxemia.
ISSN:	0300-2977 1872-9061
DOI:	10.1016/S0300-2977(01)00120-6